Compare Vanguard Value Index Fund ETF (VTV) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vanguard Value Index Fund ETF vs Health Care Select Sector SPDR Fund — how do they compare? Vanguard Value Index Fund ETF trades at $223.92, while Health Care Select Sector SPDR Fund trades at $167.05. The key difference: Vanguard Value Index Fund ETF is trading nearer its 52-week high, Health Care Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals.
| VTV | XLV | |
|---|---|---|
52-Week High | $227.51 | $175.68 |
52-Week Low | $182.86 | $134.13 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Vanguard Value ETF (VTV) trades at $224.64, down 0.8% on the day, with a neutral technical signal overall but bullish moving averages. Recent news highlights its outperformance against growth counterparts in 2026, driven by a rotation into value stocks amid market uncertainty. The ETF offers broad exposure to large-cap value equities with a minimal expense ratio of 0.03%, attracting institutional interest as seen in recent 13F filings.
VTV presents a stable investment opportunity for value-oriented investors seeking diversification and dividend income, with a declared dividend of $1.08 payable in June 2026. Risks include underperformance relative to the S&P 500 over the long term and sensitivity to economic cycles that may dampen value stock appeal.
XLV trades at $167.16, down 2.5% amid testing key support levels, with technical indicators showing mixed signals between bullish moving averages and bearish oscillators. The healthcare ETF maintains defensive appeal with upcoming dividend payments and sector rotation benefits during potential Fed tightening. Recent options activity shows increased put volume, suggesting some near-term caution among traders.
Healthcare sector strength and defensive positioning support XLV's long-term outlook, though near-term technical weakness and sector-specific headwinds from failed drug trials present risks. The ETF's low expense ratio and diversified healthcare exposure provide stability, with earnings momentum and FDA approvals driving fundamental strength.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Vanguard Value Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the CRSP US Large Cap Value Index, a broadly diversified index predominantly made up of value stocks of large US companies. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VTV →About Health Care Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →
